$2.76 Billion is the total value of PFM Health Sciences, LP's 85 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 70.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $94,599,000 | +36.0% | 1,115,949 | +33.0% | 3.42% | +29.0% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $88,505,000 | +4.4% | 3,383,233 | +1.1% | 3.20% | -1.0% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $74,057,000 | +42.1% | 1,659,733 | +22.0% | 2.68% | +34.8% |
| PEN | Buy | PENUMBRA INC | $68,262,000 | +199.9% | 360,030 | +97.0% | 2.47% | +184.6% |
| Buy | ERASCA INC | $56,667,000 | +73.0% | 7,264,981 | +23.5% | 2.05% | +64.0% | |
| PRTA | Buy | PROTHENA CORP PLC | $50,944,000 | +443.7% | 840,238 | +143.5% | 1.84% | +416.2% |
| SGEN | Buy | SEAGEN INC | $49,972,000 | +0.0% | 365,215 | +29.3% | 1.81% | -5.1% |
| New | OAK STR HEALTH INCnote 3/1 | $48,857,000 | – | 63,000,000 | +100.0% | 1.77% | – | |
| XLK | New | SELECT SECTOR SPDR TRput | $45,552,000 | – | 383,500 | +100.0% | 1.65% | – |
| QURE | Buy | UNIQURE NV | $44,899,000 | +7.7% | 2,393,311 | +7.0% | 1.62% | +2.1% |
| BIIB | New | BIOGEN INCcall | $44,536,000 | – | 166,800 | +100.0% | 1.61% | – |
| ABBV | Buy | ABBVIE INC | $42,566,000 | +12.9% | 317,163 | +28.8% | 1.54% | +7.0% |
| IQV | Buy | IQVIA HLDGS INC | $41,496,000 | -13.7% | 229,081 | +3.3% | 1.50% | -18.2% |
| VERV | Buy | VERVE THERAPEUTICS INC | $40,149,000 | +210.9% | 1,168,808 | +38.3% | 1.45% | +194.7% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $39,684,000 | +23.4% | 480,256 | +42.0% | 1.44% | +17.0% |
| PEN | New | PENUMBRA INCcall | $39,342,000 | – | 207,500 | +100.0% | 1.42% | – |
| BIIB | New | BIOGEN INC | $37,200,000 | – | 139,326 | +100.0% | 1.35% | – |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $34,903,000 | – | 4,515,216 | +100.0% | 1.26% | – |
| HCA | New | HCA HEALTHCARE INC | $32,206,000 | – | 175,235 | +100.0% | 1.16% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $30,976,000 | +177.2% | 1,289,073 | +122.0% | 1.12% | +163.1% |
| Buy | PROCEPT BIOROBOTICS CORP | $21,457,000 | +83.6% | 517,526 | +44.8% | 0.78% | +74.0% | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $19,299,000 | +128.4% | 344,868 | +111.2% | 0.70% | +116.8% |
| OSH | Buy | OAK STR HEALTH INC | $17,724,000 | +74.2% | 722,844 | +16.8% | 0.64% | +65.2% |
| GBIO | Buy | GENERATION BIO CO | $16,003,000 | -12.0% | 3,013,712 | +8.7% | 0.58% | -16.6% |
| EDIT | Buy | EDITAS MEDICINE INC | $15,656,000 | +110.2% | 1,279,054 | +103.1% | 0.57% | +99.3% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $15,259,000 | – | 180,000 | +100.0% | 0.55% | – |
| HOWL | Buy | WEREWOLF THERAPEUTICS INC | $12,699,000 | +79.4% | 2,815,654 | +62.7% | 0.46% | +70.0% |
| OM | New | OUTSET MED INC | $11,620,000 | – | 729,413 | +100.0% | 0.42% | – |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $10,020,000 | -35.3% | 9,320,584 | +2.3% | 0.36% | -38.6% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $9,581,000 | -19.9% | 4,094,488 | +3.7% | 0.35% | -24.1% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $8,590,000 | – | 130,366 | +100.0% | 0.31% | – |
| New | NEVRO CORPnote 2.750% 4/0 | $8,519,000 | – | 9,000,000 | +100.0% | 0.31% | – | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $8,324,000 | – | 121,880 | +100.0% | 0.30% | – |
| PRAX | Buy | PRAXIS PRECISION MEDICINES I | $7,851,000 | -2.8% | 3,458,525 | +4.9% | 0.28% | -7.8% |
| CANO | New | CANO HEALTH INC | $6,736,000 | – | 776,893 | +100.0% | 0.24% | – |
| PRTA | New | PROTHENA CORP PLCcall | $4,881,000 | – | 80,500 | +100.0% | 0.18% | – |
| CMPS | Buy | COMPASS PATHWAYS PLCsponsored ads | $4,267,000 | +0.4% | 397,711 | +1.3% | 0.15% | -4.9% |
| LUNG | New | PULMONX CORP | $3,327,000 | – | 199,703 | +100.0% | 0.12% | – |
| EPIX | Buy | ESSA PHARMA INC | $2,690,000 | -11.2% | 1,478,252 | +53.7% | 0.10% | -16.4% |
| CELC | New | CELCUITY INC | $1,410,000 | – | 140,426 | +100.0% | 0.05% | – |
| ZLAB | New | ZAI LAB LTDadr | $808,000 | – | 23,612 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.